These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6343980)

  • 61. SME-2-producing Serratia marcescens isolate from Switzerland.
    Poirel L; Wenger A; Bille J; Bernabeu S; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2282-3. PubMed ID: 17420208
    [No Abstract]   [Full Text] [Related]  

  • 62. Pigments and antibiogram of transconjugants from nonpigmented mutants of Serratia marcescens.
    Qian HL; Feng JS; Tsang JC
    Microbios; 1982; 33(132):101-10. PubMed ID: 7050637
    [TBL] [Abstract][Full Text] [Related]  

  • 63. RNA‑seq analyses of antibiotic resistance mechanisms in Serratia marcescens.
    Li Z; Xu M; Wei H; Wang L; Deng M
    Mol Med Rep; 2019 Jul; 20(1):745-754. PubMed ID: 31180518
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationship between pigment producibility and drug resistance in Serratia marcescens.
    Muto Y; Tsuji A; Kaneko Y; Goto S
    Microbiol Immunol; 1981; 25(11):1101-8. PubMed ID: 7035842
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of Serratia marcescens porins in antibiotic resistance.
    Ruiz N; Montero T; Hernandez-Borrell J; Viñas M
    Microb Drug Resist; 2003; 9(3):257-64. PubMed ID: 12959404
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pigmentation and acriflavine resistance in Serratia marcescens.
    Woods DR; Mosmann TR; Hanson S; Hendry DA
    J Bacteriol; 1971 Nov; 108(2):765-9. PubMed ID: 4942763
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Antimicrobial activities of gentamicin against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K; Fukumoto T
    Jpn J Antibiot; 1990 Oct; 43(10):1674-84. PubMed ID: 2128340
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transfer of antimicrobial resistance in Serratia marcescens.
    Bhujwala RA; Shriniwas ; Dutta S
    Indian J Med Res; 1984 Jan; 79():22-7. PubMed ID: 6373583
    [No Abstract]   [Full Text] [Related]  

  • 70. Infection with netilmicin resistant Serratia marcescens in a special care baby unit.
    Lewis DA; Hawkey PM; WattsJA ; Speller DC; Primavesi RJ; Fleming PJ; Pitt TL
    Br Med J (Clin Res Ed); 1983 Dec; 287(6406):1701-5. PubMed ID: 6315130
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vivo effect of ciprofloxacin on plasmid-mediated resistance.
    Mehtar S; Blakemore PH; Ellis K
    Chemioterapia; 1987 Jun; 6(2 Suppl):210-1. PubMed ID: 3334559
    [No Abstract]   [Full Text] [Related]  

  • 72. R plasmids coding for gentamicin, tobramycin, and carbenicillin resistance in Serratia, Klebsiella and Escherichia coli strains from a single clinical source.
    Knothe H; Kettner M; Kopsová D; Krcméry V
    Chemotherapy; 1977; 23(1):37-43. PubMed ID: 401718
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Novel 6'-N-Aminoglycoside Acetyltransferase, AAC(6')-Ial, from a Clinical Isolate of Serratia marcescens.
    Tada T; Miyoshi-Akiyama T; Shimada K; Dahal RK; Mishra SK; Ohara H; Kirikae T; Pokhrel BM
    Microb Drug Resist; 2016 Mar; 22(2):103-8. PubMed ID: 26270859
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antibiograms and lipid contents of pigmented and nonpigmented strains of Serratia marcescens.
    Miller MA; Chang CY; Tsang JC
    Antimicrob Agents Chemother; 1973 Jul; 4(1):66-8. PubMed ID: 4598846
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tn292l, a transposon encoding fosfomycin resistance.
    García-Lobo JM; Ortiz JM
    J Bacteriol; 1982 Jul; 151(1):477-9. PubMed ID: 6282810
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relation of cell wall lipid content of Serratia marcescens to resistance to antimicrobial agents.
    Winshell EB; Neu HC
    Antimicrob Agents Chemother; 1974 Jul; 6(1):73-5. PubMed ID: 15828173
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Astromicin-induced membrane damage in Serratia marcescens.
    Umeda A; Murata K; Amako K
    Antimicrob Agents Chemother; 1986 Sep; 30(3):398-402. PubMed ID: 3535663
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The in vivo and in vitro postantibiotic effect of aminoglycosides using a clinically isolated micro-organism.
    Arai S; Kawamura R; Kamiya H; Ishii T; Sakurai M
    Acta Paediatr Jpn; 1993 Feb; 35(1):17-21. PubMed ID: 8460539
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Studies on pigmentation of Serratia marcescens. IV. Analysis of syntrophic pigment.
    GREEN JA; WILLIAMS RP
    J Bacteriol; 1957 Nov; 74(5):633-6. PubMed ID: 13481002
    [No Abstract]   [Full Text] [Related]  

  • 80. A novel type of resistant bacteria induced by gentamicin.
    Li K; Farmer JJ; Coppola A
    Trans N Y Acad Sci; 1974 May; 36(5):396-415. PubMed ID: 4604021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.